Preferred Label : selexipag;
MeSH note : structure in first source;
CISMeF synonym : ACT 293987; NS-304;
MeSH synonym : 2-(4-((5,6-diphenylpyrazin-2-yl)(isopropyl)amino)butoxy)-N-(methylsulfonyl)acetamide;
MeSH hyponym : ACT293987; ACT-293987;
Is substance : O;
UNII : 5EXC0E384L;
InChIKey : QXWZQTURMXZVHJ-UHFFFAOYSA-N;
Origin ID : C523468;
UMLS CUI : C2000145;
ATC code(s)
CISMeF manual mappings
Currated CISMeF NLP mapping
MeSH indexing information
MeSH term(s) associated for indexing
Pharmacological action(s)
Record concept(s)
See also (suggested by CISMeF)
Semantic type(s)
UMLS correspondences (same concept)
Validated automatic mappings to BTNT
https://ansm.sante.fr/tableau-marr/selexipag
2024
false
false
false
France
French
risk management
Uptravi
medication errors
selexipag
patients guideline
guidelines for drug use
Wrong dose
selexipag
---
https://www.has-sante.fr/portail/jcms/c_2803897/fr/uptravi
https://www.has-sante.fr/portail/jcms/c_2803897/fr/uptravi-selexipag-antithrombotique
2017
false
false
false
France
French
acetamides
pyrazines
selexipag
selexipag
treatment outcome
hypertension, pulmonary
drug therapy, combination
administration, oral
receptors, prostaglandin
adult
aged
prodrugs
antihypertensive agents
antihypertensive agents
evaluation of the transparency committee
guidelines for drug use
selexipag
acetamides
pyrazines
---
https://www.ema.europa.eu/medicines/human/EPAR/Uptravi
2016
false
false
false
United Kingdom
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
acetamides
pyrazines
selexipag
selexipag
drug approval
europe
treatment outcome
hypertension, pulmonary
drug therapy, combination
administration, oral
continuity of patient care
receptors, prostaglandin
product surveillance, postmarketing
adult
aged
drug interactions
pregnancy
breast feeding
prodrugs
drug evaluation, preclinical
antihypertensive agents
antihypertensive agents
selexipag
acetamides
pyrazines
---